LYMPHANGIOLEIOMYOMATOSIS
Clinical trials for LYMPHANGIOLEIOMYOMATOSIS explained in plain language.
Never miss a new study
Get alerted when new LYMPHANGIOLEIOMYOMATOSIS trials appear
Sign up with your email to follow new studies for LYMPHANGIOLEIOMYOMATOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Early trial tests new drug mixes for Tough-to-Treat cancers
Disease control OngoingThis early-stage trial aims to find safe doses and understand side effects of several drug combinations for patients with advanced cancers that haven't responded to standard treatments. The study involves 155 participants with various advanced or metastatic cancers and some rare …
Matched conditions: LYMPHANGIOLEIOMYOMATOSIS
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New scan aims to predict drug effectiveness for rare lung disease
Knowledge-focused OngoingThis study is testing whether a special type of PET scan can act as an early sign that the drug rapamycin is working for patients with Lymphangioleiomyomatosis (LAM), a rare lung disease. Seven adult patients with LAM and a specific kidney tumor will receive one or two of these s…
Matched conditions: LYMPHANGIOLEIOMYOMATOSIS
Phase: PHASE1, PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:43 UTC